ZS/DC P013 dendritic cell vaccine - Zhongsheng Kangyuan Biotechnology
Alternative Names: ZS/DC-P013 dendritic cell vaccine - Zhongsheng Kangyuan BiotechnologyLatest Information Update: 28 Aug 2024
At a glance
- Originator Zhongsheng Kangyuan Biotechnology
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Liver cancer
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for phase-0 development in Liver-cancer in China (IV, Infusion)
- 23 Jul 2021 Phase-0 for Liver cancer in China (IV) as at July 2021 (Zhongsheng Kangyuan Biotechnology pipeline, July 2021)